MRI与PSMA-PET时代前列腺癌多模态影像不一致发现的应对
本文为综述,讨论前列腺癌不同影像模态及其评分框架之间、以及与临床病理结果之间常见的不一致,分析其对治疗决策的影响,并指出跨模态判读协调仍需更多研究,多学科团队讨论是优化处理的关键。
要点
- 不同影像模态的评分体系不同,模态间及与病理结果不一致并不少见。
- 不一致常给治疗决策带来挑战,尤其在新模态适应证动态变化时。
- 多学科团队讨论是处理不一致、优化前列腺癌患者管理的关键。
核心结论
- 不同影像模态或判读框架之间、以及与临床病理结果之间的不一致并不少见,常导致决策困难。
- 跨模态判读协调仍需更多研究,存在不一致时多学科团队讨论是优化管理的关键。
研究设计与样本
- 综述,检索范围与纳入文献数原文未报告。
- 围绕前列腺癌不同分期中多种影像模态的判读框架及其不一致展开讨论。
临床应用与阅片要点
- 存在影像不一致时,原文强调多学科团队讨论对优化前列腺癌患者管理的关键作用。
局限性
- 原文指出跨模态判读的协调仍需更多研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Various imaging modalities play key roles throughout the different stages of prostate cancer. Each imaging modality has different strengths and weaknesses and various scoring systems or frameworks are used to interpret their findings. Discordances between imaging modalities or interpretation frameworks, and even with clinicopathological findings are not uncommon. Discordances often lead to challenges in the decision-making process, especially with dynamically changing indications for newer imaging modalities. While more research is needed on harmonizing interpretations across different modalities, multidisciplinary team discussion is key to optimizing management of patients with prostate cancer when such discordances are present. In this comprehensive review, we take a deep dive in to these various discordances seen in clinical practice and explore their clinical implications.
引用
- Woo S, Masci B, Becker AS, et al. Navigating discordant findings in multimodality imaging of prostate cancer in the MRI and PSMA-PET era. Radiol Med. 2025. PMID: 41182592. doi:10.1007/s11547-025-02140-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。